Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. New Broad Band Rare-Earth-Doped Glasses For Optical Fiber Communications

    SBC: KIGRE, INC.            Topic: BMDO01T001

    Kigre is developing new scalable high gain broad band rare earth doped laser oscillator/amplifier glass materials & diode pump architectures in support of high energy and high power laser applications. What's new, exciting and different about Kigre's laser glass materials and constructs is the ability to efficiently store and extract 1000-10,000x more laser power from ultra-short gain lengths and ...

    STTR Phase II 2004 Department of DefenseDefense Advanced Research Projects Agency
  2. Mid-infrared Fiber Laser Based on Super-Continuum

    SBC: OMNI SCIENCES, INC.            Topic: ST051008

    Infrared counter-measures require a mid-infrared laser operating between 2-5 microns with time-averaged powers of 5W and more. Omni Sciences, Inc.'s (OSI's) Mid-Infra-Red FIber Laser (MIRFIL) will generate continuous light over the mid-IR, 2-5 microns, with time-averaged power scalable to more than 5W. The MIRFIL is a practical super-continuum (SC) source using commercial off-the-shelf (COTS) la ...

    STTR Phase II 2007 Department of DefenseDefense Advanced Research Projects Agency
  3. A Rapid assay for RNA targeted drugs: Instrumentation Supplement

    SBC: NUBAD, LLC            Topic: 300

    DESCRIPTION provided by applicant Some of the most significant therapies that treat disease target nucleic acids Drugs that target nucleic acid include cancer drugs antibiotics and antivirals Combined these classes of drugs have annual sales worldwide of $ billion Antibiotics that target nucleic acids account for $ billion of the $ billion of sales annuall for all antibiotics an ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Assessing the Bite Counter as a Tool for Food Intake Monitoring: Phase II

    SBC: BITE TECHNOLOGIES, LLC            Topic: 300

    DESCRIPTION provided by applicant Self monitoring has been described as the andquot cornerstone of the behavioral treatment of obesityandquot Consistent self monitoring of energy intake is associated with improved dietary adherence and weight loss and maintenance The problem is that individuals are notoriously bad at self monitoring their intake and suffer from an underreporting bias The s ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Reversal of Myocardial Infarction by Localized Stimulation

    SBC: Micro Vide, LLC            Topic: NHLBI

    DESCRIPTION provided by applicant Heart attacks i e myocardial infarction or MI occur in more than million patients annually Advances in pharmacological therapy have dramatically improved survival following the initial MI Consequently the number of patients with previous MI continues to increase and as a result put in jeopardy millions of patients for development of heart failure I ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Improving Outcomes for Mechanically Ventilated Patients with the Digital EZ Board

    SBC: VIDATAK, LLC            Topic: 600

    DESCRIPTION provided by applicant Effective communication between patients and healthcare professionals is essential to achieve positive clinical outcomes Patients who are unable to communicate effectively e g patients with limited English proficiency LEP those who are hearing impaired aphasic or have oral tracheal intubation experience extreme frustration panic anxiety sleeplessne ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. PSSC: Pictorial Structures for Scene Context

    SBC: Soar Technology, Inc.            Topic: ST14B003

    We propose to develop a Visual Context Understanding (Vis-CU) intelligent agent.Vis-CU tightly integrates vision processing with cognitive reasoning.The vision processing draws the wide array of vision processing capabilities, integrated through the University of Michigans sparse component model into the Soar Cognitive Architecture (Soar).This tight integration facilitates the development of a ric ...

    STTR Phase II 2016 Department of DefenseDefense Advanced Research Projects Agency
  8. Cognitive Bias in Online Communication Activities (C-BOCA)

    SBC: Soar Technology, Inc.            Topic: N13AT024

    This effort will analyze publicly available online communication data, uniquely applying empirical results from the cognitive bias literature, to quantify the impact of cognitive biases on exposure to, use of, and propagation of online information. SoarTech, with its partners, will develop and evaluate methods to identify and measure cognitive biases in online information environments. The team wi ...

    STTR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  9. Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma

    SBC: Leukogene Therapeutics Inc.            Topic: 102

    Project Summary Abstract Multiple MyelomaMMis the second most common form of blood cancer and remains an incurable and deadly diseaseProteasome inhibitorPItherapy is a cornerstone in the treatment of MMbut resistance to this class of agent is an emerging challenge in the clinicNew therapeutic approaches that specifically target resistance are needed to maximize responses and ultimately produce cur ...

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. A nanoparticle delivery system for CRISPR/Cas9 based therapeutics

    SBC: ATGC Inc.            Topic: 100

    Abstract Applications of customizable nucleases such as CRISPRclustered regularly interspaced short palindromic repeatsCasCRISPR associated proteinhave enabled efficient and precise gene correction in vitroand hold promises for eventually achieving in vivo gene correction therapyHoweverto apply CRISPR Casin therapeutic settingsseveral major challenges remain to be addressedihomologous recombinatio ...

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government